DEVELOPMENT & MANUFACTURE OF ORAL DOSAGE FORMS

本合同的目标是开发和制造奥口可乐 将用于人体临床试验的药物的剂型 在国家癌症研究所的赞助下进行。那些药物会 通常由抗癌和抗艾滋病化合物组成。剂型将 包括但不限于片剂、肠溶片、胶囊 软胶囊剂、胶囊化颗粒剂和口服粉 解决办法。承包商应对试验性和试验性产品进行测试 制造业追求的是实力、身份和性能特征。 设施、设备和程序应符合FDA规定 现行良好制造规范(CGMP)。

The objective of this Contract is the development and manufacture of oral dosage forms of drugs which will be used for human clinical trials carried out under the auspices of the National Cancer Institute. Those drugs will usually consist of anti-cancer and anti-AIDS compounds. Dosage forms will include but not be limited to tablets, enteric coated tablets, capsules, soft gelatin capsules, encapsulated granules and oral powders and solutions. The contractor shall test the products from experimental and manufacturing runs for strength, identity and performance characteristics. Facilities, equipment and procedures shall conform to FDA prescribed Current Good Manufacturing Practices (CGMP).